FDA Releases Companion Dx Guidance Broad In Scope, Limited In Detail

FDA released long-awaited draft guidance on the development of drugs with companion diagnostics July 12, but the 12-page document’s concise nature left some in the industry longing for more insight.

More from Archive

More from Pink Sheet